Drugs Used in Skin Disorders Practice Questions

Q: Which is the first generation topical retinoid?

Retinoic acid (tretinoin). ***Retinoic acid (tretinoin)*** - **Tretinoin** is the **first generation topical retinoid** and is a naturally occurring derivative of **vitamin A**. - It is widely used for **acne vulgaris** and **photoaging** due to its potent effects on cellular differentiation and proliferation. *Adapalene* - **Adapalene** is a **third-generation topical retinoid** known for its selective action on **retinoic acid receptors (RARs)**. - It causes less irritation compared to tretinoin while maintaining significant efficacy in **acne treatment**. *Tazarotene* - **Tazarotene** is another **third-generation topical retinoid**, known as a **prodrug** that is converted to its active form, **tazarotenic acid**. - It is particularly effective for **psoriasis** and **acne**, demonstrating potent anti-inflammatory effects. *Acitretin* - **Acitretin** is a **second-generation oral retinoid** primarily used for severe **psoriasis**. - It is not a topical retinoid and has a systemic mechanism of action, with significant potential for **teratogenicity**.

Q: Which of the following is a melanising agent?

Methoxsalen. ***Methoxsalen*** - **Methoxsalen** is a **psoralen** derivative used in combination with ultraviolet A (UVA) light therapy (**PUVA**) to treat skin conditions like **vitiligo** and **psoriasis**. - It works by intercalating into DNA and forming adducts, which, when exposed to UVA light, stimulate **melanocyte proliferation** and melanin production. *Dapsone* - **Dapsone** is an **antibiotic** and **anti-inflammatory** agent primarily used to treat leprosy, dermatitis herpetiformis, and certain other dermatoses. - It works by inhibiting folic acid synthesis in bacteria and suppressing neutrophil function, and it **does not stimulate melanin production**. *Kojic acid* - **Kojic acid** is a common ingredient in cosmetic products used to **lighten skin** by inhibiting the enzyme **tyrosinase**, which is essential for melanin synthesis. - Therefore, it is a **depigmenting agent**, not a melanizing agent. *Minocycline* - **Minocycline** is a **tetracycline antibiotic** used to treat various bacterial infections, including acne and Lyme disease. - A known side effect of minocycline is **hyperpigmentation** of the skin, nails, and teeth, but this pigmentation is due to deposition of breakdown products of the drug and not due to stimulation of melanin production by melanocytes.

Q: Which of the following is the most potent topical corticosteroid?

Clobetasol propionate. ***Clobetasol propionate*** - **Clobetasol propionate** is recognized as one of the most potent **Class I topical corticosteroids**, used for severe inflammatory skin conditions. - Its high potency allows for effective suppression of severe inflammation and pruritus, but also carries a greater risk of **adverse effects** with prolonged use. *Triamcinolone acetonide* - **Triamcinolone acetonide** is a **medium-potency** topical corticosteroid (Class IV-V), less potent than clobetasol propionate. - It is commonly used for moderate inflammatory skin conditions, such as eczema and psoriasis, but not for severe cases requiring maximum potency. *Hydrocortisone acetate* - **Hydrocortisone acetate** is a **low-potency** topical corticosteroid (Class VII), making it the least potent option listed. - It's often used for mild inflammatory conditions, sensitive areas like the face, or for less severe conditions requiring minimal corticosteroid strength. *Betamethasone valerate* - **Betamethasone valerate** is a **medium-to-high potency** topical corticosteroid (Class III-V), placing it among stronger corticosteroids but still less potent than clobetasol propionate. - It is effective for moderate to severe inflammatory skin conditions but does not reach the highest level of potency demonstrated by clobetasol.

Q: Which drug would treat both dermatophytosis and candidal infection?

Ketoconazole. ***Ketoconazole*** - **Ketoconazole** is an **imidazole antifungal** that inhibits the synthesis of ergosterol, a crucial component of fungal cell membranes. - It has a broad spectrum of activity, effectively treating both **dermatophytes** (causing dermatophytosis) and **Candida species** (causing candidal infections). *Griseofulvin* - **Griseofulvin** works by inhibiting **fungal cell division** and is primarily used for **dermatophyte infections** of the skin, hair, and nails. - It is **ineffective against Candida species** because Candida cells do not take up the drug. *Nystatin* - **Nystatin** is a **polyene antifungal** agent that disrupts the fungal cell membrane by binding to ergosterol. - Its activity is almost exclusively limited to **Candida infections**, and it is not effective against dermatophytes. *Tolnaftate* - **Tolnaftate** is a topical antifungal agent that acts by inhibiting **ergosterol biosynthesis**, specifically targeting **squalene epoxidase**. - It is primarily effective against **dermatophyte infections** but has little or no activity against Candida species.

Q: A 32-year-old gay male presented to his community STD clinic with perianal condyloma acuminatum. Physical removal was recommended due to the size of the lesions, along with topical immunomodulatory therapy. Which of the following drugs was most likely selected?

Imiquimod (topical immunomodulator). ***Imiquimod (topical immunomodulator)*** - **Imiquimod** is a topical immunomodulator that stimulates the production of **cytokines**, such as **interferon-alpha**, thereby enhancing the local immune response against **HPV-infected cells**. - It is a common and effective therapy for external **genital** and **perianal warts (condyloma acuminatum)**, often used in conjunction with other treatments, especially for larger lesions. *Acyclovir (antiviral)* - **Acyclovir** is an antiviral drug primarily used to treat infections caused by the **herpes simplex virus (HSV)** and **varicella-zoster virus (VZV)**, not **human papillomavirus (HPV)**. - While condyloma acuminatum is caused by **HPV**, acyclovir has no therapeutic effect against it. *5-Fluorouracil (chemotherapy)* - **5-Fluorouracil** is a **cytotoxic chemotherapy agent** that inhibits **DNA synthesis** and is sometimes used topically for certain skin cancers and actinic keratoses. - While it can be used for warts, it is generally considered an off-label use and is **less commonly chosen** for perianal condyloma acuminatum due to significant local irritation and potential for ulceration. *Podophyllin (antimitotic agent)* - **Podophyllin** is a **cytotoxic agent** that arrests cell division and is used topically to treat some types of warts by causing **necrosis** of the wart tissue. - While effective, its application has to be carefully performed by a clinician, and it is **contraindicated in pregnancy**; it is also not classified as an immunomodulator.

Q: What is the primary mechanism of action of Apremilast?

Inhibition of PDE-4. ***Inhibition of PDE-4*** - **Apremilast** is a small molecule inhibitor specifically targeting **phosphodiesterase 4 (PDE4)**. - By inhibiting PDE4, Apremilast increases intracellular levels of **cyclic adenosine monophosphate (cAMP)**, leading to a modulation of pro-inflammatory and anti-inflammatory mediators. *Inhibition of IL-17* - This mechanism is primarily associated with biologics like **secukinumab** and **ixekizumab**, which are monoclonal antibodies that directly block IL-17A. - While IL-17 is involved in inflammatory conditions treated by Apremilast, Apremilast does not directly inhibit IL-17 itself. *Inhibition of CD25* - **CD25** is the alpha subunit of the **IL-2 receptor**, and its inhibition (e.g., by basiliximab) is primarily used for **immunosuppression** in organ transplantation to prevent T-cell activation. - This mechanism is not related to the action of Apremilast. *Inhibition of IL-23* - This mechanism is characteristic of biologics such as **guselkumab**, **risankizumab**, and **tildrakizumab**, which target the p19 subunit of **IL-23**. - These drugs are used in conditions like psoriasis, but their mechanism differs from Apremilast's PDE4 inhibition.

Q: Fixed drug eruptions can be seen more frequently with which of the following medications?

Sulfonamide. ***Sulfonamide*** - **Fixed drug eruptions (FDEs)** are particularly associated with sulfonamides due to their common use and mechanism of action, which can lead to localized, recurrent reactions upon re-exposure. - Sulfonamides, such as **sulfamethoxazole-trimethoprim**, are well-known triggers for these specific cutaneous adverse drug reactions. *Penicillin* - While penicillin can cause a wide variety of **hypersensitivity reactions**, including rashes and anaphylaxis, FDEs are not a typical or frequent presentation. - **Maculopapular rashes** and **urticaria** are more characteristic of penicillin allergies. *Cetirizine* - Cetirizine is an **antihistamine** primarily used to treat allergic reactions, and it is rarely associated with drug-induced skin eruptions. - It is generally considered a **safe medication** with a low incidence of adverse skin effects. *Roxithromycin* - Roxithromycin is a **macrolide antibiotic** and, while it can cause skin reactions, FDEs are uncommon. - Macrolides are more frequently linked to **generalized hypersensitivity reactions** or **photosensitivity**.

Q: In the treatment of superficial bacterial skin infections, what is the standard concentration of tetracycline ointment typically prescribed for topical application?

1%. ***1%*** - **Tetracycline 1% ointment** is the standard and effective concentration for topical application in superficial bacterial skin infections [1]. - This concentration ensures adequate therapeutic levels of the antibiotic at the site of infection while minimizing systemic absorption. *0.10%* - A concentration of **0.10% tetracycline** is generally too low to be effective against most common bacterial skin infections. - This insufficient concentration could lead to treatment failure and potentially contribute to antibiotic resistance. *0.50%* - While higher than 0.10%, **0.50% tetracycline** is still considered a suboptimal concentration for treating superficial bacterial skin infections. - It might not achieve the necessary bactericidal or bacteriostatic effects required for successful eradication of the infection. *5%* - A **5% concentration of tetracycline** is typically too high for topical application and could increase the risk of local irritation or sensitization. - While potentially more potent, it is not the standard and usually offers no significant therapeutic advantage over the 1% concentration for superficial infections, while increasing potential side effects.

Q: Which of the following conditions is not an indication for using thalidomide for treatment?

Impetigo. ***Impetigo*** - **Thalidomide** is an immunomodulatory drug with potent anti-inflammatory and anti-angiogenic properties, but it has no role in treating bacterial skin infections like **impetigo**. - Impetigo is a **bacterial skin infection** typically caused by *Staphylococcus aureus* or *Streptococcus pyogenes*, requiring **antibiotic treatment**. *Prurigo nodularis* - **Thalidomide** is used off-label for severe, refractory cases of **prurigo nodularis** due to its immunomodulatory and antipruritic effects, reducing inflammation and itch. - Its mechanism in this context involves modulating **cytokine production** and inhibiting angiogenesis. *Behcet's disease* - **Thalidomide** is an effective treatment for various manifestations of **Behcet's disease**, particularly **recurrent oral and genital ulcers** and skin lesions. - Its immunomodulatory actions help to suppress the inflammatory response characteristic of this **vasculitic** condition. *Erythema nodosum leprosum* - **Thalidomide** is the **treatment of choice** for severe cases of **erythema nodosum leprosum (ENL)**, an immune-mediated inflammatory complication of leprosy. - It rapidly controls the acute inflammatory symptoms by reducing **TNF-alpha** production and other **pro-inflammatory cytokines**.

Q: The most potent topical corticosteroid is:

Clobetasol propionate cream 0.05%. ***Clobetasol propionate cream 0.05%*** - **Clobetasol propionate** is recognized as a **super high-potency (Class I)** topical corticosteroid, making it one of the most potent available. - It is often used for severe inflammatory skin conditions that are resistant to less potent corticosteroids. *Hydrocortisone butyrate cream 0.1%* - **Hydrocortisone butyrate** is a **medium-potency (Class IV)** corticosteroid, significantly less potent than clobetasol propionate. - While effective for mild to moderate dermatoses, it would not be considered the "most potent." *Betamethasone valerate cream 0.1%* - **Betamethasone valerate** is a **medium-potency (Class III/IV)** corticosteroid, depending on the specific formulation. - It falls in an intermediate range of potency, not reaching the super high potency of clobetasol propionate. *Clobetasone butyrate cream 0.5%* - **Clobetasone butyrate** is a **mild-potency (Class VI/VII)** corticosteroid, much less potent than clobetasol propionate despite the similar-sounding name. - It is typically used for less severe conditions or in more sensitive areas where stronger corticosteroids are contraindicated.

Question 1

Which is the first generation topical retinoid?

Accepted Answer

Retinoic acid (tretinoin)

Answer

Adapalene

Answer

Tazarotene

Answer

Acitretin

Question 2

Which of the following is a melanising agent?

Accepted Answer

Methoxsalen

Answer

Dapsone

Answer

Kojic acid

Answer

Minocycline

Question 3

Which of the following is the most potent topical corticosteroid?

Accepted Answer

Clobetasol propionate

Answer

Triamcinolone acetonide

Answer

Hydrocortisone acetate

Answer

Betamethasone valerate

Question 4

Which drug would treat both dermatophytosis and candidal infection?

Accepted Answer

Ketoconazole

Answer

Nystatin

Answer

Griseofulvin

Answer

Tolnaftate

Question 5

A 32-year-old gay male presented to his community STD clinic with perianal condyloma acuminatum. Physical removal was recommended due to the size of the lesions, along with topical immunomodulatory therapy. Which of the following drugs was most likely selected?

Accepted Answer

Imiquimod (topical immunomodulator)

Answer

Acyclovir (antiviral)

Answer

5-Fluorouracil (chemotherapy)

Answer

Podophyllin (antimitotic agent)

Question 6

What is the primary mechanism of action of Apremilast?

Accepted Answer

Inhibition of PDE-4

Answer

Inhibition of IL-17

Answer

Inhibition of CD25

Answer

Inhibition of IL-23

Question 7

Fixed drug eruptions can be seen more frequently with which of the following medications?

Accepted Answer

Sulfonamide

Answer

Penicillin

Answer

Roxithromycin

Answer

Cetirizine

Question 8

In the treatment of superficial bacterial skin infections, what is the standard concentration of tetracycline ointment typically prescribed for topical application?

Accepted Answer

1%

Answer

0.10%

Answer

0.50%

Answer

5%

Question 9

Which of the following conditions is not an indication for using thalidomide for treatment?

Accepted Answer

Impetigo

Answer

Prurigo nodularis

Answer

Behcet's disease

Answer

Erythema nodosum leprosum

Question 10

The most potent topical corticosteroid is:

Accepted Answer

Clobetasol propionate cream 0.05%

Answer

Betamethasone valerate cream 0.1%

Answer

Clobetasone butyrate cream 0.5%

Answer

Hydrocortisone butyrate cream 0.1%

Drugs Used in Skin Disorders — MCQs

Drugs Used in Skin Disorders — MCQs

On this page

Practice by Chapter

Want unlimited practice?